Üstün F, Ustabaşıoğlu F E, Tokuç B, Bülbül B Yımaz, Çelik M, Aytürk S
Trakya University, Faculty of Medicine, Department of Nuclear Medicine, Edirne.
Trakya University, Faculty of Medicine, Department of Radiology, Edirne.
Acta Endocrinol (Buchar). 2023 Jul-Sep;19(3):292-300. doi: 10.4183/aeb.2023.292. Epub 2024 Feb 1.
Paget Disease (PD) is usually asymptomatic and discovered incidentally, it is known that it is exhibited low to high grade increased F-18 FDG uptake.
In this study, we investigated the distinguishability of FDG PET/CT in incidental PD cases from other bone diseases and at different stages of the disease.
In this cross-sectional, descriptive study, "Paget" identification associated with PET/CT reports was found in 69 of 18,119 studies (~3.8%). Of the 45 patients (33 males and 12 females) eligible for inclusion in the study, 35.6% had monostotic and 64.4% had polyostotic disease (p>0.5). There was no statistically significant difference in biochemical parameters between groups.
According to the radiological appearance of the patients, 36 were in the mixed stage and 9 were in the blastic stage. Only the difference in ALP and creatinine values between the groups was statistically significant. SUVmax, SUVmean and HU values were found to be statistically significantly higher in pagetoid bones compared to control bone lesions. For SUVmax for PD bone lesion we found the 2.55 cutoff point with a sensitivity of 91% and a specificity of 84%.
The specific radiological appearance of bone lesions and the evaluation of metabolic activity compared to normal bone seem to help differentiate PD from other lesions. Prospective studies are needed in the differentiation of FDG's disease stage and treatment response evaluation. The ability to differentiate between benign and malignant FDG avid bone lesions in oncological patients' enables appropriate patient management, including avoiding unnecessary additional invasive procedures such as bone biopsy.
佩吉特病(PD)通常无症状,多为偶然发现,已知其表现为F-18 FDG摄取呈低到高等级增加。
在本研究中,我们调查了FDG PET/CT在偶然发现的PD病例与其他骨病以及疾病不同阶段之间的鉴别能力。
在这项横断面描述性研究中,在18119项研究中的69项(约3.8%)PET/CT报告中发现了与“佩吉特病”相关的诊断。符合纳入研究条件的45例患者(33例男性和12例女性)中,35.6%为单骨型,64.4%为多骨型疾病(p>0.5)。各组之间生化参数无统计学显著差异。
根据患者的放射学表现,36例处于混合期,9例处于成骨期。仅组间碱性磷酸酶(ALP)和肌酐值的差异具有统计学显著性。与对照骨病变相比,畸形骨中的最大标准摄取值(SUVmax)、平均标准摄取值(SUVmean)和HU值在统计学上显著更高。对于PD骨病变的SUVmax,我们发现截断点为2.55,灵敏度为91%,特异性为84%。
骨病变的特定放射学表现以及与正常骨相比的代谢活性评估似乎有助于将PD与其他病变区分开来。在FDG疾病分期的鉴别和治疗反应评估方面需要进行前瞻性研究。在肿瘤患者中区分良性和恶性FDG摄取性骨病变的能力有助于进行适当的患者管理,包括避免不必要的额外侵入性检查,如骨活检。